Company intelligence / Profile preview

Dmanna

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Dmanna is a consumer health company specializing in natural solutions for urinary tract health. The company's flagship product is a daily D-mannose supplement designed to prevent recurrent urinary tract infections (UTIs) by inhibiting the adhesion of E. coli bacteria to the bladder wall. Dmanna operates primarily through a subscription-based model, providing clinical-strength, pre-measured powder packets that can be easily integrated into a daily routine. By focusing on preventative care, the company aims to reduce the reliance on antibiotics for chronic urinary health issues.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeNutraceutical
Industry: Food & Nutrition

Beyond the preview

Go deeper on Dmanna.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dmanna.

Explore the full profile